10 Health Care Stocks That Have Flatlined

Despite solid performance by the sector, it seems there's no life left in these stocks

    View All  
10 Health Care Stocks That Have Flatlined

Last year was a difficult one for health care stocks, partially due to investors’ concerns over the federal health care debate. But 2011 is shaping up to be a whole different story for health care stocks. The sector has outpaced the S&P 500, up 6.3% in the first quarter compared to 4.2% for the broad market index.

But this does not mean all health care stocks are a good investment right now. In fact, some very established, well-known names have been underperforming the sector, as well as the overall market. Most have declined significantly in the past 12 months, and they have fallen as much as 7% year-to-date.

There’s simply no room in your portfolio for this kind of lackluster performance, so check out our list of health care stocks to sell.

Health Care Stock to Sell #1 Johnson & Johnson (JNJ)

Known around the world for its range of brand-name consumer health care products, Johnson & Johnson (NYSE: JNJ) is also starting to become known for its poor stock performance. In the past year, shares of JNJ are down almost 9%, and year-to-date, the big pharma stock is off more than 4%. The company’s quarterly earnings growth was down 12% year-over-year in its last income statement.

Health Care Stock to Sell #2 Merck & Co (MRK)

Year-to-date, Merck & Co Inc. (NYSE: MRK) has shown lackluster performance, falling 7%. In the past 12 months, the company known for its prescription medicines, vaccines, biologic therapies, animal health and consumer care products, has watched its stock decline almost 9%, compared to an 11%-plus gain for the Dow Jones Industrial Average.

Health Care Stock to Sell #3 Sanofi-Aventis (SNY)

Researcher, developer, manufacturer and marketer of health care products, Sanofi-Aventis (NYSE: SNY), is another pharmacy stock having a rough year. Over the past 12 months, SNY stock has dropped 1%, compared to gains by the broader markets. More alarming is SNY’s quarterly earnings growth, which was reported as -67% in its last income statement.

Health Care Stock to Sell #4 Abbott Laboratories (ABT)

Since reaching a high in mid-October, Abbott Laboratories (NYSE: ABT) has experienced a slip in stock price of 4%. Known for discovering, developing, manufacturing and selling health care products, ABT just posted a quarterly earnings growth of -6% in its most recent income statement.


Article printed from InvestorPlace Media, http://investorplace.com/2011/04/health-care-stocks-to-sell-jnj-mrk-sny-abt-amgn-teva-mdt-gild-bax-celg/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.